Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
DELISTED
Macatawa Bank Corp
MCBC
| $10.3M | 0.01% |
1,323,462
-700
| -0.1% | -$5.07K |
2013 Q2
28 quarters
|
|
1202
Vitamin Cottage Natural Grocers
NGVC
$696M
| $10.3M | 0.01% |
694,615
+127,600
| +23% | +$1.55M |
2015 Q2
20 quarters
|
|
1203
DELISTED
2U Inc
TWOU
| $10.3M | 0.01% |
+9,047
| New | +$8.08M |
2020 Q2
0 quarters
|
|
1204
Compañía de Cervecerías Unidas
CCU
$2.01B
| $10.3M | 0.01% |
718,933
+246,600
| +52% | +$3.55M |
2017 Q2
12 quarters
|
|
1205
Vertiv
VRT
$92.1B
| $10.3M | 0.01% |
+759,000
| New | +$8.84M |
2020 Q2
0 quarters
|
|
1206
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13B
| $10.3M | 0.01% |
+94,200
| New | +$9.75M |
2020 Q2
0 quarters
|
|
1207
DELISTED
G. Willi-Food International
WILC
| $10.3M | 0.01% |
659,768
-1,794
| -0.3% | -$23.6K |
2013 Q2
28 quarters
|
|
1208
Exelon
EXC
$43.4B
| $10.3M | 0.01% |
397,220
-2,415,342
| -86% | -$64.1M |
2017 Q2
12 quarters
|
|
1209
Zurn Elkay Water Solutions
ZWS
$7.79B
| $10.2M | 0.01% |
729,699
+644,390
| +755% | +$8.45M |
2018 Q3
7 quarters
|
|
1210
Vanguard Intermediate-Term Treasury ETF
VGIT
$39.7B
| $10.2M | 0.01% |
145,000
+97,500
| +205% | +$6.86M |
2020 Q1
1 quarter
|
|
1211
Youdao
DAO
$2.1B
| $10.2M | 0.01% |
272,300
+223,700
| +460% | +$5.5M |
2020 Q1
1 quarter
|
|
1212
Ingredion
INGR
$6.06B
| $10.2M | 0.01% |
122,500
-71,400
| -37% | -$5.84M |
2016 Q3
15 quarters
|
|
1213
DELISTED
Fonar
FONR
| $10.2M | 0.01% |
475,491
-33,725
| -7% | -$689K |
2013 Q2
28 quarters
|
|
|
SPPI
1214
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $10.1M | 0.01% |
3,002,073
+744,331
| +33% | +$2.17M |
2014 Q4
22 quarters
|
|
1215
Western New England Bancorp
WNEB
$275M
| $10.1M | 0.01% |
1,751,139
-1,850
| -0.1% | -$10.3K |
2013 Q2
28 quarters
|
|
1216
Perion Network
PERI
$353M
| $10.1M | 0.01% |
1,937,139
-246,034
| -11% | -$1.26M |
2013 Q2
28 quarters
|
|
1217
Benchmark Electronics
BHE
$2.86B
| $10.1M | 0.01% |
468,300
-11,500
| -2% | -$241K |
2013 Q2
28 quarters
|
|
1218
Axon Enterprise
AXON
$33.7B
| $10.1M | 0.01% |
102,952
-11,000
| -10% | -$889K |
2020 Q1
1 quarter
|
|
1219
DELISTED
Denny's
DENN
| $10.1M | 0.01% |
999,200
-1,345,711
| -57% | -$13.8M |
2013 Q2
28 quarters
|
|
|
HCCI
1220
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $10.1M | 0.01% |
577,200
-41,430
| -7% | -$698K |
2015 Q4
18 quarters
|
|
1221
Community Trust Bancorp
CTBI
$1.36B
| $10M | 0.01% |
306,382
-18,723
| -6% | -$602K |
2014 Q1
25 quarters
|
|
1222
Tejon Ranch
TRC
$446M
| $10M | 0.01% |
695,378
+147,379
| +27% | +$2.05M |
2018 Q3
7 quarters
|
|
1223
Gerdau
GGB
$10.1B
| $9.99M | 0.01% |
4,251,114
-1,912,538
| -31% | -$3.63M |
2020 Q1
1 quarter
|
|
|
HUD
1224
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $9.98M | 0.01% |
2,048,526
+336,986
| +20% | +$1.76M |
2018 Q3
7 quarters
|
|
1225
Universal Electronics
UEIC
$71.1M
| $9.96M | 0.01% |
212,800
+13,100
| +7% | +$551K |
2018 Q4
6 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.